About Zenara
Zenara is a Healthcare company based in Hyderabad (India) founded in 2004, and was acquired by Cambrex in November 2010. Specialty contract development and manufacturing services are offered for pharmaceuticals. The company has 231 employees. Its chief executive, as recorded, is Srinivas Arutla. Zenara offers products and services including Oral Solids, Liquids, and Parenteral Formulations. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity in India is Zenara Pharma India Private Limited (U24230MH2004PTC147284). Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Zenara was established in 2004 in Hyderabad, India, as a contract development and manufacturing organization within the pharmaceutical sector. Formulation development, manufacturing, and technology transfers for solid oral dosage forms are handled by the company. Nicotine Replacement Therapy products, such as medicated chewing gums and lozenges, are also developed and supplied. Operations are conducted as a wholly owned subsidiary of Cambrex, with a focus on regulatory services and licensing.
- Headquarters Hyderabad, India
- Employees 231
- Stage Acquired
- SectorsHealthcare
- Website zenara.com
- Social LinkedIn
- Acquired by Cambrex (Nov 2010)
- Legal Name Zenara Pharma India Private Limited
- Date of Incorporation 02 Jul, 2004
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Zenara
Zenara is associated with 2 registered companies on The Company Check; the primary company is Zenara Pharma India Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zenara Pharma India Private Limited CIN U24230MH2004PTC147284 | Strike Off | 02 Jul 2004 | Mumbai, Maharashtra | 2 | View details | ||
| Zenara Pharma Private Limited CIN U24239TG2004PTC042894 | Active | 18 Mar 2004 | Hyderabad, Telangana | ₹85.7 Cr | 205 | 4 | View details |
Products & Services of Zenara
Zenara offers a comprehensive portfolio of products and services, including Oral Solids, Liquids, and Parenteral Formulations.
Produces solid medications for global distribution.
Manufactures liquid formulations for healthcare needs.
Develops injectable drugs for medical applications.
Investors in Zenara
Zenara has secured backing from 1 investor. Prominent investors backing the company include Cambrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO of complex small molecule APIs, including highly potent APIs | 1981 | cambrex.com | East Rutherford, United States |
Investor details for Zenara
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Zenara Pharma India Private Limited (Zenara)
Zenara Pharma India Private Limited is the primary company behind Zenara. The boards of the 2 registered companies of Zenara currently have 4 directors; the longest-serving is Rangaswamy Srinivasa Raghavan Gandarvakottai, appointed in 2007. 32 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rangaswamy Srinivasa Raghavan Gandarvakottai DIN 01855204 | Director | 29 Mar 2007 | 19 yrs 7 mo | Zenara Pharma India Private Limited |
| Jaison Vazhakal Abraham DIN 01817600 | Director | 03 Mar 2008 | 18 yrs 8 mo | Zenara Pharma India Private Limited |
| Manikreddy Pullagurla DIN 01850939 | Director | 21 Jan 2017 | 9 yrs 9 mo | Zenara Pharma Private Limited |
| Jagadeesh Babu Rangisetty DIN 01725762 | Director | 21 Jan 2017 | 9 yrs 9 mo | Zenara Pharma Private Limited |
People of Zenara
1 people are tracked at Zenara (1 in leadership); the tracked headcount is 231.
| Name | Role | Group |
|---|---|---|
Srinivas Arutla | CEO | Leadership |
Complete people profiles for Zenara
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Zenara
2 dated milestones of Zenara across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Zenara is founded.
- Exit Acquired by Cambrex.
Competitors of Zenara
Zenara has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. |
Detailed competitors of Zenara
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Zenara (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zenara
Complete news archive for Zenara
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zenara
Zenara was founded in 2004.
Zenara is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Srinivas Arutla is the CEO of Zenara, as recorded in our data.
Zenara has 231 employees.
Annual revenue of Zenara is $4.99M as on Mar 31, 2022.
Zenara was established in 2004 in Hyderabad, India, as a contract development and manufacturing organization within the pharmaceutical sector. Formulation development, manufacturing, and technology transfers for solid oral dosage forms are handled by the company. Nicotine Replacement Therapy products, such as medicated chewing gums and lozenges, are also developed and supplied. Operations are conducted as a wholly owned subsidiary of Cambrex, with a focus on regulatory services and licensing.
Zenara's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.
Zenara offers Oral Solids, Liquids, and Parenteral Formulations.
Zenara has 1 investor. Key investors include Cambrex.
Zenara is associated with 2 legal entities: Zenara Pharma India Private Limited, Zenara Pharma Private Limited.
Yes. Zenara was acquired by Cambrex in November 2010.
The legal entities of Zenara currently have 6 directors, including Rangaswamy Srinivasa Raghavan Gandarvakottai, Jaison Vazhakal Abraham, Manikreddy Pullagurla and others.

